Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology
Link
http://www.nature.com/articles/s41408-017-0037-4.pdf
Reference100 articles.
1. Terpos, E. et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J. Clin. Oncol. 31, 2347–2357 (2013).
2. Terpos, E., Berenson, J., Cook, R. J., Lipton, A. & Coleman, R. E. Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease. Leukemia 24, 1043–1049 (2010).
3. Terpos, E., Roodman, G. D. & Dimopoulos, M. A. Optimal use of bisphosphonates in patients with multiple myeloma. Blood 121, 3325–3328 (2013).
4. Gavriatopoulou, M., Dimopoulos, M. A., Kastritis, E. & Terpos, E. Emerging treatment approaches for myeloma-related bone disease. Expert. Rev. Hematol. 10, 217–228 (2017).
5. Terpos, E., Berenson, J., Raje, N. & Roodman, G. D. Management of bone disease in multiple myeloma. Expert. Rev. Hematol. 7, 113–125 (2014).
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper;British Journal of Haematology;2024-09-09
2. Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma;Critical Reviews in Oncology/Hematology;2024-09
3. Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe;Patient Preference and Adherence;2024-09
4. The impact of biomarkers of malignancy (IMWG SLiM criteria) in myeloma in a real‐world population: Clinical characteristics, therapy and outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR);British Journal of Haematology;2024-07-04
5. Myeloma‐associated hemophagocytic lymphohistiocytosis – A comprehensive case study and a novel chemotherapy‐free approach with anakinra;eJHaem;2024-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3